Elevated Rates Of Obesity And Heart Disease Fuel Expansion Of The Type 2 Diabetes Market Driver: Leading Transformation in the Type 2 Diabetes Market in 2025

What combination of drivers is leading to accelerated growth in the type 2 diabetes market?
The ongoing surge in obesity and heart disease rates is anticipated to catalyze the expansion of the type 2 diabetes market. Obesity, a health condition characterized by excessive body fat accumulation to an extent that it becomes detrimental, and heart disease, which covers a spectrum of conditions impacting the heart and blood vessels, both contribute to the development of type 2 diabetes. Elevated body weight heightens the potential for insulin resistance, resulting in increased blood sugar levels and the onset of type 2 diabetes. Conversely, high blood sugar levels can lead to damage to the blood vessels and nerves that regulate the heart and circulatory system, resulting in heart disease. To illustrate, the World Health Organization (WHO), a Swiss-based global body, noted in March 2024 that roughly an eighth of the world population battled obesity, corresponding to 2.5 billion adult overweight individuals, 890 million of whom were classified as obese. Additionally, about 43% of the adults were overweight, and 16% were categorized as obese. Furthermore, the count of overweight children under five years of age stood at 37 million. This rise in obesity and heart disease rates, therefore, is fuelling the type 2 diabetes market's growth. Market Driver for Type 2 Diabetes: A Growing Aging Population Stimulates Type 2 Diabetes Market Expansion

Get Your Type 2 Diabetes Market Report Here:
https://www.thebusinessresearchcompany.com/report/type-2-diabetes-global-market-report

What is the projected compound annual growth rate (CAGR) of the type 2 diabetes market from 2025 to 2034, and what factors influence it?
The market for Type 2 diabetes has seen substantial growth in recent years. It's expected to expand from $48.14 billion in 2024 to $51.96 billion in 2025 with a compound annual growth rate (CAGR) of 7.9%. The growth in the previous period can be linked to changes in lifestyle and diet, an aging populace, advancements in pharmaceuticals, and public health initiatives.

The market size for type 2 diabetes is predicted to witness robust expansion in the coming years, reaching $72.22 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 8.6%. The surge in growth over the forecast period can be tied to the worldwide diabetes outbreak, bespoke healthcare, advancements in technology, and shifts in healthcare policies. Key trends during this forecast period will be digital healthcare and remote medicine, preventative measures and early intervention strategies, Artificial Intelligence (AI) and Machine Learning (ML) applications, and metabolic surgeries.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13050&type=smp

How are the latest trends influencing the growth of the type 2 diabetes market?
In the type 2 diabetes market, dominant corporations are working on unique products like Mounjaro, with a focus on increasing safety and efficacy standards for patients with diabetes. Drugs like Mounjaro are being developed to enhance the convenience, efficacy, or safety of diabetes treatment better than current medications. The primary goal of these innovative drugs is to improve the regulation of blood sugar, reduce harmful side effects, and deal with other health-related complications. For example, Eli Lilly and Co., a pharmaceutical firm based in the United States, gained approval for Mounjaro (tripeptide) injection for adults with type 2 diabetes from the U.S. Food and Drug Administration, a governmental organization also based in the United States in May 2022. This approval was given to incorporate the drug into diet and exercise routines for better blood sugar management. Tirzepatide, a unique, dual-action type 2 diabetes treatment, is a weekly injection targeting two hormones involved in blood sugar regulation, namely glucagon-like peptide 1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP). GLP-1 aids in escalating insulin production and decreasing glucagon production, while GIP functions to boost insulin production. Tirzepatide appears to be a hopeful new therapeutic alternative for individuals with type 2 diabetes, including those who have previously seen little to no positive response to other treatments.

What are the major segments of the type 2 diabetes market and their role in driving growth?
The type 2 diabetes market covered in this report is segmented -

1) By Drug Class: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors, Sulfonylureas And Other Insulin Secretagogues, Biguanides, SodiumGlucose Cotransporter 2 Inhibitors, Other Drug Classes
2) By Application: Glycemic Control, Cardiovascular Safety, Hypoglycemia Avoidance, Other Applications
3) By End-User: Children, Adults

Subsegments:
1) By Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin
2) By Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Liraglutide, Semaglutide, Dulaglutide, Exenatide
3) By Thiazolidinediones: Pioglitazone, Rosiglitazone
4) By Alpha-Glucosidase Inhibitors: Acarbose, Miglitol
5) By Sulfonylureas And Other Insulin Secretagogues: Glimepiride, Glipizide, Glyburide
6) By Biguanides: Metformin
7) By Sodium-Glucose Cotransporter 2 Inhibitors: Canagliflozin, Dapagliflozin, Empagliflozin
8) By Other Drug Classes: Amylin Analogues, Bile Acid Sequestrants, Dopamine Agonists

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13050

North America was the largest region in the type 2 diabetes market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in type 2 diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the key firms paving the way for growth in the type 2 diabetes market?
Major companies operating in the type 2 diabetes market are F. Hoffmann-La Roche AG, Merck and Co. Inc., Novartis AG, AstraZeneca PLC, Abbott Laboratories, Sanofi SA, Medtronic PLC, Takeda Pharmaceutical Company, GlaxoSmithKline plc., Eli Lilly and Company, Novo Nordisk A/S, Johnson And Johnson Private Limited, Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Dexcom Inc., Amgen Inc., Insulet Corporation, Ascensia Diabetes Care, Byram Healthcare, Beta Bionics, Onduo LLC, DarioHealth, One Drop, Bigfoot Biomedical Inc., Digbi Health, MySugr GmbH, Senseonics Holdings Inc., Provention Bio Inc., Vida Health Inc., Diathrive Health.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13050&type=smp

What Is Covered In The Type 2 Diabetes Global Market Report?

•Market Size Forecast: Examine the type 2 diabetes market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the type 2 diabetes market for a structured understanding.
•Key Players Overview: Analyze major players in the type 2 diabetes market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the type 2 diabetes market.
•Segment Contributions: Evaluate how different segments drive overall growth in the type 2 diabetes market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the type 2 diabetes market.
•Industry Challenges: Identify potential risks and obstacles affecting the type 2 diabetes market.
•Competitive Landscape: Review strategic developments in the type 2 diabetes market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.